54 LIFE THREATENING VARICELLA ZOSTER VIRUS ENCEPHALITIS IN AN IMMUNOCOMPETENT PATIENT

1999 ◽  
Vol 11 (2) ◽  
pp. 152
Author(s):  
M RAGALLER ◽  
H THEILEN ◽  
U REUNER ◽  
D M ALBRECHT
2016 ◽  
Vol 34 (11) ◽  
pp. 2257.e1-2257.e2
Author(s):  
Candice D. Jordan ◽  
Frederick Korley ◽  
Bachar Hamade

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Lorenzo Stefano Pelloni ◽  
Raffaele Pelloni ◽  
Luca Borradori

Abstract Background Herpes zoster, also known as shingles, results from reactivation of the varicella-zoster virus. It commonly presents with burning pain and vesicular lesions with unilateral distribution and affects the thoracic and cervical sites in up to 60 and 20% of cases, respectively. The branches of the trigeminal nerves are affected in up to 20% of cases. Multidermatomal involvement of the trigeminal nerves has been only anecdotally described in immunocompetent subjects. Case presentation A 71-year-old previously healthy male presented with grouped vesicular and impetiginized lesions with crusts on the left half of the face of two-weeks duration. The lesions first developed on the left nasal tip and progressively worsened with unilateral appearance of vesicular lesions on the left forehead, face, ala nasi, nasal vestibulum and columella, as well as on the left side of hard and soft palate. The affected edematous erythematous areas corresponded to the distribution of the left ophthalmic (V1) and maxillary (V2) branches of the trigeminal nerve, including the infraorbital and nasopalatine nerves of the maxillary branch responsible for the oral cavity involvement. Viral DNA amplification by polymerase chain reaction confirmed the presence of Varicella zoster virus. The patient was started on oral valaciclovir with rapid recovery. Conclusions Among immunocompetent patients, herpes zoster is considered a self-limited localized infection. Our observation provides a rare but paradigmatic example of herpes zoster with involvement of both the ophthalmic and maxillary divisions of the trigeminal nerve in an immunocompetent patient. Immunocompetence status and age-specific screening should be warranted in case of atypical involvement and according to the patient’s history, while treatment with antiviral drugs should be rapidily initiated in patients at risk.


2013 ◽  
Vol 52 (9) ◽  
pp. 1003-1003 ◽  
Author(s):  
Takeshi Saraya ◽  
Manami Inoue ◽  
Hajime Takizawa ◽  
Hajime Goto

Infection ◽  
2006 ◽  
Vol 34 (6) ◽  
pp. 352-354 ◽  
Author(s):  
T. Kin ◽  
M. Hirano ◽  
Y. Tonomura ◽  
S. Ueno

Author(s):  
Rahila Ansari ◽  
Lindsey B Rosen ◽  
Andrea Lisco ◽  
Don Gilden ◽  
Steven M Holland ◽  
...  

Abstract Background Although most cases of varicella or zoster are self-limited, patients with certain immune deficiencies may develop severe or life-threatening disease. Methods We studied a patient with varicella-zoster virus (VZV) central nervous system (CNS) vasculopathy and as part of the evaluation, tested his plasma for antibodies to cytokines. We reviewed the literature for cases of varicella or zoster associated with primary and acquired immunodeficiencies. Results We found that a patient with VZV CNS vasculopathy had antibody that neutralized interferon (IFN)-α but not IFN-γ. The patient’s plasma blocked phosphorylation in response to stimulation with IFN-α in healthy control peripheral blood mononuclear cells. In addition to acquired immunodeficiencies like human immunodeficiency virus (HIV) or autoantibodies to IFN, variants in specific genes have been associated with severe varicella and/or zoster. Although these genes encode proteins with very different activities, many affect IFN signaling pathways, either those that sense double-stranded RNA or cytoplasmic DNA that trigger IFN production, or those involved in activation of IFN stimulated genes in response to binding of IFN with its receptor. Conclusions Immune deficiencies highlight the critical role of IFN in control of VZV infections and suggest new approaches for treatment of VZV infection in patients with certain immune deficiencies.


2020 ◽  
Vol 59 (13) ◽  
pp. 1643-1647
Author(s):  
Tomohiro Suzuki ◽  
Syuichi Tetsuka ◽  
Tomoko Ogawa ◽  
Ritsuo Hashimoto ◽  
Shinya Okada ◽  
...  

1993 ◽  
Vol 123 (3) ◽  
pp. 418-422 ◽  
Author(s):  
Christopher C. Silliman ◽  
Davol Tedder ◽  
John W. Ogle ◽  
Jack Simon ◽  
B.K. Kleinschmidt-DeMasters ◽  
...  

2009 ◽  
Vol 119 (4) ◽  
pp. 628-630 ◽  
Author(s):  
Görkem Eskiizmir ◽  
Uzdan Uz ◽  
Esra Taşkiran ◽  
Halis Ünlü

Sign in / Sign up

Export Citation Format

Share Document